A new study analyzing 1,691 Australian medical records has found that younger patients under 50 with metastatic colorectal cancer—cancer that has spread beyond the original site—often have better survival rates compared to older patients. This challenges a common belief that early-onset cancer is more aggressive. The findings suggest that age alone is not enough to predict how the disease will progress, and that the biological characteristics of the tumor and specific genetic changes in the cancer cells are more important in determining a patient’s outlook and the best course of treatment. Early-onset colorectal cancer, which is diagnosed in people under 50, is more commonly found in women and tends to occur on the left side of the colon. These tumors are often linked to certain genetic mutations, such as BRAF, KRAS, and NRAS. These mutations are more influential than age in predicting how the cancer will behave and how it will respond to treatment. The study highlights that understanding these genetic factors could lead to more personalized and effective treatment strategies. The PELICan hypothesis suggests that long-term exposure to stress-related factors like smoking, alcohol use, obesity, or drug use may lead to changes in how genes are expressed—known as epigenetic modifications—that could contribute to the development of early-onset colorectal cancer. While this idea has not yet been fully confirmed, it offers a possible explanation for the growing number of younger individuals being diagnosed with the disease. The study emphasizes the need to focus more on the biology of the tumor and its genetic makeup rather than just the patient's age when assessing the severity of colorectal cancer and deciding on treatment. It also calls for more research into prevention and screening methods, especially as the rate of early-onset colorectal cancer continues to rise. This shift in focus could lead to earlier detection and more tailored approaches to managing the disease.